Ueda, P., Svanström, H., Melbye, M., Eliasson, B., Svensson, A., Franzén, S., . . . Pasternak, B. (2018). Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: Nationwide register based cohort study. BMJ (Online), 363, k4365. https://doi.org/10.1136/bmj.k4365
Citace podle Chicago (17th ed.)Ueda, Peter, et al. "Sodium Glucose Cotransporter 2 Inhibitors and Risk of Serious Adverse Events: Nationwide Register Based Cohort Study." BMJ (Online) 363 (2018): k4365. https://doi.org/10.1136/bmj.k4365.
Citace podle MLA (9th ed.)Ueda, Peter, et al. "Sodium Glucose Cotransporter 2 Inhibitors and Risk of Serious Adverse Events: Nationwide Register Based Cohort Study." BMJ (Online), vol. 363, 2018, p. k4365, https://doi.org/10.1136/bmj.k4365.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..